SAFETY
Clinical trials for SAFETY explained in plain language.
Never miss a new study
Get alerted when new SAFETY trials appear
Sign up with your email to follow new studies for SAFETY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could Lab-Grown nerve cells help repair spinal cord damage?
Disease control Not yet recruitingThis study tests a new treatment called XS228, made from stem cells, to help repair nerve damage in people who had a spinal cord injury 2 to 12 weeks ago. About 60 adults with severe but incomplete paralysis will receive either a single injection of XS228 into their spinal fluid …
Matched conditions: SAFETY
Phase: PHASE2 • Sponsor: XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
New study tests website to prevent firearm injuries in homes
Prevention Not yet recruitingThis study tests a website called the Family Safety Check-In to see if it helps families with children store their firearms more safely. About 548 parents who have guns at home and store them unsafely will use the website and report back. The goal is to prevent accidental shootin…
Matched conditions: SAFETY
Phase: NA • Sponsor: Seattle Children's Hospital • Aim: Prevention
Last updated May 26, 2026 04:13 UTC
-
Bar staff training aims to stop violence before it starts
Prevention Not yet recruitingThis study tests a program called Safe Night Out, which trains bar staff to spot and stop sexual and intimate partner violence. Researchers will compare 25 bars that use the program with 25 that don't, tracking 150 staff and 500 patrons over 18 months. The goal is to see if the p…
Matched conditions: SAFETY
Sponsor: University of California, San Diego • Aim: Prevention
Last updated May 18, 2026 12:02 UTC
-
Nasal spray could replace pills for Pre-Surgery calm
Symptom relief Not yet recruitingThis study tests whether a nasal spray containing dexmedetomidine can safely sedate patients before surgery with minimal monitoring. About 564 adults will receive either the spray or a placebo 45 minutes before anesthesia. Researchers will track breathing and heart problems, how …
Matched conditions: SAFETY
Phase: PHASE4 • Sponsor: Sichuan Provincial People's Hospital • Aim: Symptom relief
Last updated May 26, 2026 04:11 UTC
-
New drug YR011 put to the test: first human trial begins
Knowledge-focused Not yet recruitingThis early-stage study tests a new oral drug called YR011 in 64 healthy adults to see if it is safe and how the body processes it. Participants receive either the drug or a placebo in single or multiple doses. The goal is to gather safety data, not to treat any disease.
Matched conditions: SAFETY
Phase: PHASE1 • Sponsor: Hangzhou Yirui Pharmaceutical Technology Co., Ltd • Aim: Knowledge-focused
Last updated May 26, 2026 04:11 UTC